Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2026-01-01 @ 7:46 AM
Study NCT ID:
NCT05616793
Status:
RECRUITING
Last Update Posted:
2025-12-19
First Post:
2022-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
Sponsor:
Opus Genetics, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06-15
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-07
First Submit QC Date:
None
Study First Post Date:
2022-11-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-17
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED